Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B. Pappalardi, Rab K. Prinjha, Alexandra Stowell et al.|Nature Cancer|2021Cited by 279
N-Nitrosodimethylamine investigations in Muta™Mouse define point-of-departure values and demonstrate less-than-additive somatic mutant frequency accumulationsAnthony M Lynch, John W. Wills, Jonathan Howe et al.|Mutagenesis|2024Cited by 20